ADVB: Advanced Biomed Inc Broker Consensus Forecast

Symbol and logo of brand Advanced Biomed Corp (ADVB)

The market price of Advanced Biomed Inc (ADVB), as confirmed by the chart, reflects the dynamics of a company developing robotic systems for automated blood analysis to replace manual diagnostic labor. The current figure stands at 0.00, which correlates with a period of high capital expenditure amid weak profit inflows. Business development is further complicated by international logistics challenges for components from Asia and patent conflicts.

Advanced Biomed - ADVB Analyst Consensus Forecast (period 03/07/2025 - 11/11/2026)

Analytical breakdowns for Advanced Biomed Inc (ADVB)

- stock value and consensus price forecast:
Stock Price advanbiomed.com|ADVB - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Advanced Biomed Corp|ADVB - Real Price to Acquire Entire Company
- business book valuation details:
Net Assets per Single Share Advanced Biomed|ADVB - Book Capitalization|Market Value to Book Value Ratio advanbiomed.com|ADVB - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Advanced Biomed Inc|ADVB - Long-Term Debt to Capital|Short-Term Debt to Capital advanbiomed.com|ADVB - Company Debts|Debt to Book Value Ratio Advanced Biomed Corp|ADVB - Company Long-Term Debts|Company Current Liabilities Advanced Biomed|Immediate Liquidity advanbiomed.com
- financial results and valuation multiples details:
ADVB - Company Net Income|Expected Net Income Advanced Biomed Inc|ADVB - Price to Earnings Ratio|Future Price to Earnings Multiple advanbiomed.com|ADVB - PEG Multiple|Enterprise Value to EBITDA Ratio Advanced Biomed Corp|ADVB - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Advanced Biomed|ADVB - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months advanbiomed.com|ADVB - Earnings growth in current year|Expected net earnings per share growth next year Advanced Biomed Inc
Fundamental company analysis:Advanced Biomed Inc. (ADVB)
Original product of Advanced Biomed Inc

For Advanced Biomed Inc (ADVB), whose diagnostic chip operations are constrained by strict reagent disposal regulations, the median target price reflects the professional consensus on the business's capitalization. This indicator aggregates the expectations of institutional players, enabling a timely detection of declining confidence in the issuer and helping to avoid prolonged losses during a systematic downward revision of the asset's fair value.

Competing companies

Analyst Consensus Forecast beigene.com (ONC)|Analyst Consensus Forecast HALO (Halozyme)|RVMD: Broker Consensus Forecast|AAPG: Consensus Target|CGON: Price Target Chart|URGN: Analyst Consensus Forecast|BCAX (bicara.com) - Price Target Chart|PSNL (Personalis) - Analyst Consensus Forecast|Consensus Target Erasca Inc (ERAS)|Analyst Consensus Forecast DCTH|Analyst Consensus Forecast Y-mAbs Corp (YMAB)|Price Target Chart Aura Biosciences, Inc. AURA|CADL: Broker Consensus Forecast|Accuray - Analyst Consensus Forecast|SELLAS Life Sciences (SLS) - Consensus Target|ACTU: Analyst Consensus Forecast|Average Forecast Price Citius Oncology Inc (CTOR)|Price Target Chart TuHURA Biosciences Inc.|TARA: Fair Value Consensus|Consensus Target FATE (Fate Therapeutics)|WHWK (aadibio.com) - Fair Value Consensus|Analyst Consensus Forecast TCRX (TScan Therapeutics, Inc.)|CSBR - Consensus Target|XBIT: Consensus Target|CVM - Analyst Consensus Forecast|OS Therapies (OSTX) - Price Target Chart|Radiopharm Theranostics Ltd - Fair Value Consensus|ARTV (Artiva Biotherapeutics Inc.) - Analyst Consensus Forecast|Average Forecast Price Adlai Nortye Limited ANL|Analyst Consensus Forecast VERU|Analyst Consensus Forecast tempesttx.com (TPST)|Analyst Consensus Forecast XLO (Xilio Therapeutics)|RENB: Broker Consensus Forecast|MURA: Consensus Target|KAPA: Price Target Chart|OKUR: Analyst Consensus Forecast|CytoMed Therapeutics Limited (GDTC) - Analyst Consensus Forecast|Price Target Chart Curis Inc.|Broker Consensus Forecast APLM (Apollomics Corp)|Analyst Consensus Forecast THAR|Consensus Target Genprex Inc GNPX|Analyst Consensus Forecast CLDI (Calidi Biotherapeutics, Inc.)|Sunshine Biopharma Inc. (SBFM) - Average Forecast Price|Xenetic Bio - Analyst Consensus Forecast|SLRX (Salarius Pharmaceuticals Inc) - Broker Consensus Forecast|PPBT (Purple Biotech Corp) - Consensus Target|American Oncology Network, Inc. - Fair Value Consensus|BGNE (BeiGene, Ltd.) - Analyst Consensus Forecast|Price Target Chart CKPT|Analyst Consensus Forecast ELEV|Analyst Median Target icadmed.com|Price Target Chart Ikena Oncology IKNA|Notable Labs Corp (NTBL) - Average Forecast Price|VIRX - Price Target Chart|morphosys.com (MOR) - Consensus Target|NAYA: Analyst Consensus Forecast|Average Forecast Price Ascentage Pharma Group International (AAPGV)